| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,497,494 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,497,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -126.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice PresidentOfficer |
• – – |
2011-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,073 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice PresidentOfficer |
• – – |
2012-01-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,073 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
737 |
5,790 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,151 |
2,018 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,025 |
5,140 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,543 |
8,297 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,402 |
12,395 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• – – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,985 |
18,604 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,006 |
25,847 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,921 |
36,206 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,823 |
63,702 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,634 |
51,409 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,475 |
99,944 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,198 |
96,428 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,267 |
145,929 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
49,093 |
169,956 |
0 |
- |
|
| CGTX |
Cognition Therapeutics In... |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,084 |
186,195 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,788 |
197,639 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
VP, Antisense Drug Discovery |
• – – |
2012-09-06 |
4 |
OE |
$5.25 |
$63,163 |
D/D |
12,031 |
17,415 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• • – |
2012-01-01 |
4 |
D |
$6.13 |
$3,597 |
D/D |
(587) |
5,660 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2012-07-01 |
4 |
A |
$6.13 |
$1,906 |
D/D |
311 |
5,971 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-03-05 |
4 |
OE |
$6.81 |
$124,214 |
D/D |
18,240 |
23,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
OE |
$7.21 |
$119,274 |
D/D |
16,493 |
23,341 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-08-26 |
4 |
OE |
$7.25 |
$253,267 |
D/D |
27,344 |
11,813 |
0 |
- |
|
116 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
